News
The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make ...
A promising new study from the Knight Family DIAN-TU research group at Washington University School of Medicine has found that starting Alzheimer’s treatment years before symptoms begin could delay — ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...
A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...
Learn more about the dosage of Bupropion XL and Bupropion SR, including available strengths, form, how it’s taken, and more.
Imodium is approved by the Food and Drug Administration (FDA) to treat the symptoms of diarrhea, including traveler’s diarrhea, in adults and children over the age of 2 years.
Zepatier is approved by the Food and Drug Administration (FDA) to treat chronic hepatitis C caused by hepatitis C virus (HCV) genotypes 1 or 4. This drug is used in adults and children who are 12 ...
The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH — also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results